FDA Drug Recalls

Recalls / Class II

Class IID-1093-2023

Product

Helix CBD Clinical Cream (Menthol 7.4%), packaged in a)3 gm pouches (NDC30775-054-01), b)2 fl. oz. tubes (NDC 30775-054-02), and c) 4 fl. oz. tubes (NDC 30775-054-04), Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004

Affected lot / code info
Lot #: a) J1121011, Exp. Date 12/21/2023, b) A0921009, Exp. Date 8/18/2023, c) A0921008, Exp. Date 8/18/2023

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Parker Laboratories, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
286 Eldridge Rd, N/A, Fairfield, New Jersey 07004-2509

Distribution

Quantity
50
Distribution pattern
Nationwide within the United States, Singapore, Korea and Hong Kong

Timeline

Recall initiated
2023-08-02
FDA classified
2023-08-18
Posted by FDA
2023-08-30
Terminated
2024-06-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1093-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.